| Primary | Morning Peak Expiratory Flow (PEF) | Change in the Morning PEF from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomisation). No imputation of missing data was performed | | Posted | | Mean | Standard Deviation | Liters/min | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| | | Title | Denominators | Categories |
|---|
| | | Title | Measurements |
|---|
| - OG00012.88± 24.6
- OG00113.78± 29.7
- OG0024.59± 27.9
|
|
| |
| Secondary | Evening Peak Expiratory Flow (PEF) | Change in the Evening PEF from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomisation). No imputation of missing data was performed | | Posted | | Mean | Standard Deviation | Liters/min | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Asthma Symptom Score, Night | Change in the Asthma Symptom Score (Night) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms. | | Posted | | Mean | Standard Deviation | Units on a scale | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Asthma Symptom Score, Day | Change in the Asthma Symptom Score (Day) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms. | | Posted | | Mean | Standard Deviation | Units on a scale | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Asthma Symptom Score, Total | Change in the Asthma Symptom Score (Total) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Daily scale:0 = No symptoms; 1 = Mild symptoms; 2 = Moderate symptoms; 3 = Severe symptoms. | | Posted | | Mean | Standard Deviation | Units on a scale | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Percentage of Nights With Awakenings Due to Asthma | Change in the Percentage of Nights With Awakenings Due to Asthma from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. The participants answered "Yes" or "No" whether she/he woke up during the night due to asthma. | | Posted | | Mean | Standard Deviation | Percentage of night | | Baseline and 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Use of Rescue Medication, Night | Change in the Use of Rescue Medication (Night) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed | | Posted | | Mean | Standard Deviation | Inhalations | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Use of Rescue Medication, Day | Change in the Use of Rescue Medication (Day) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed | | Posted | | Mean | Standard Deviation | Inhalations | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Use of Rescue Medication, Total | Change in the Use of Rescue Medication (Total) from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed | | Posted | | Mean | Standard Deviation | Inhalations | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Percentage of Symptom-free Days | Change in the Percentage of Symptom-free Days from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Symptom-free Day: no symptoms (asthma symptom score=0) night and day, and no awakenings due to asthma. | | Posted | | Mean | Standard Deviation | Percentage of days | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Percentage of Asthma Control Days | Change in the Percentage of Symptom Control Days from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Asthma Control Day: no symptoms (asthma symptom score=0) night and day, no awakenings due to asthma, no rescue medication. | | Posted | | Mean | Standard Deviation | Percentage of days | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Percentage of Rescue Free Days | Change in the Percentage of Rescue Free Days from baseline (calculated as a mean using all available data for the 10 last days of run-in period) to week 6 (calculated as a mean using all available data after randomization, with run-in values as covariate). No imputation of missing data was performed. Rescue-free Day defined as day and night with no use of rescue medication. | | Posted | | Mean | Standard Deviation | Percentage of days | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |
| Secondary | Forced Expiratory Volume in 1 Second (FEV1) | Change in the FEV1from baseline to week 6 (calculated as a mean using all available data after randomization) | | Posted | | Mean | Standard Deviation | Liters | | Baseline to 6 weeks | | | | ID | Title | Description |
|---|
| OG000 | Symbicort pMDI | Symbicort®pMDI® 40/2.25 μg 2 Actuations Twice Daily | | OG001 | Symbicort Turbuhaler | Symbicort Turbuhaler® 80/4.5 μg 1 Inhalation Twice Daily | | OG002 | Pulmicort Turbuhaler | Pulmicort®Turbuhaler® 100 μg 1 Inhalation Twice Daily |
| |